240 related articles for article (PubMed ID: 28890310)
21. Assessment of the American College of Surgeons surgical risk calculator of outcomes after hepatectomy for liver tumors: Results from a cohort of 950 patients.
Donadon M; Galvanin J; Branciforte B; Palmisano A; Procopio F; Cimino M; Del Fabbro D; Torzilli G
Int J Surg; 2020 Dec; 84():102-108. PubMed ID: 33099020
[TBL] [Abstract][Full Text] [Related]
22. The American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator Has a Role in Predicting Discharge to Post-Acute Care in Total Joint Arthroplasty.
Goltz DE; Baumgartner BT; Politzer CS; DiLallo M; Bolognesi MP; Seyler TM
J Arthroplasty; 2018 Jan; 33(1):25-29. PubMed ID: 28899592
[TBL] [Abstract][Full Text] [Related]
23. A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy.
Kimura W; Miyata H; Gotoh M; Hirai I; Kenjo A; Kitagawa Y; Shimada M; Baba H; Tomita N; Nakagoe T; Sugihara K; Mori M
Ann Surg; 2014 Apr; 259(4):773-80. PubMed ID: 24253151
[TBL] [Abstract][Full Text] [Related]
24. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K
Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711
[TBL] [Abstract][Full Text] [Related]
25. Use of the American College of Surgeons NSQIP Surgical Risk Calculator for Laparoscopic Colectomy: how good is it and how can we improve it?
Cologne KG; Keller DS; Liwanag L; Devaraj B; Senagore AJ
J Am Coll Surg; 2015 Mar; 220(3):281-6. PubMed ID: 25617914
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.
McMillan MT; Allegrini V; Asbun HJ; Ball CG; Bassi C; Beane JD; Behrman SW; Berger AC; Bloomston M; Callery MP; Christein JD; Dickson E; Dixon E; Drebin JA; Fernandez-Del Castillo C; Fisher WE; Fong ZV; Haverick E; Hollis RH; House MG; Hughes SJ; Jamieson NB; Kent TS; Kowalsky SJ; Kunstman JW; Malleo G; McElhany AL; Salem RR; Soares KC; Sprys MH; Valero V; Watkins AA; Wolfgang CL; Zureikat AH; Vollmer CM
Ann Surg; 2017 May; 265(5):978-986. PubMed ID: 27232260
[TBL] [Abstract][Full Text] [Related]
27. Trends and Hospital Variations in Surgical Outcomes for Cholangiocarcinoma in New York State.
Liu H; Cen X; Suo T; Cai X; Yuan X; Shen S; Liu H; Li Y
World J Surg; 2017 Feb; 41(2):525-537. PubMed ID: 27785554
[TBL] [Abstract][Full Text] [Related]
28. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer.
Lim CS; Jang JY; Lee SE; Kang MJ; Kim SW
J Gastrointest Surg; 2012 May; 16(5):1012-8. PubMed ID: 22271243
[TBL] [Abstract][Full Text] [Related]
29. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor.
Kurosaki I; Hatakeyama K; Minagawa M; Sato D
J Gastrointest Surg; 2008 May; 12(5):907-18. PubMed ID: 17968629
[TBL] [Abstract][Full Text] [Related]
30. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute.
Nanashima A; Tobinaga S; Abo T; Machino R; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2012; 59(114):347-50. PubMed ID: 22353497
[TBL] [Abstract][Full Text] [Related]
31. Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma.
Lee EC; Park SJ; Han SS; Shim JR; Park HM; Lee SD; Kim SH
J Gastroenterol Hepatol; 2018 Apr; 33(4):958-965. PubMed ID: 28843035
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
33. Are we taking a risk with risk assessment tools? Evaluating the relationship between NSQIP and the ACS risk calculator in colorectal surgery.
Keller DS; Ho JW; Mercadel AJ; Ogola GO; Steele SR
Am J Surg; 2018 Oct; 216(4):645-651. PubMed ID: 30049434
[TBL] [Abstract][Full Text] [Related]
34. Defining perioperative risk after hepatectomy based on diagnosis and extent of resection.
Shubert CR; Habermann EB; Truty MJ; Thomsen KM; Kendrick ML; Nagorney DM
J Gastrointest Surg; 2014 Nov; 18(11):1917-28. PubMed ID: 25199947
[TBL] [Abstract][Full Text] [Related]
35. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
[TBL] [Abstract][Full Text] [Related]
36. Locally advanced gallbladder cancer: which patients benefit from resection?
Birnbaum DJ; Viganò L; Ferrero A; Langella S; Russolillo N; Capussotti L
Eur J Surg Oncol; 2014 Aug; 40(8):1008-15. PubMed ID: 24246608
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of the ACS NSQIP Online Risk Calculator Depends on How You Look at It: Results from the United States Gastric Cancer Collaborative.
Beal EW; Saunders ND; Kearney JF; Lyon E; Wei L; Squires MH; Jin LX; Worhunsky DJ; Votanopoulos KI; Ejaz A; Poultsides G; Fields RC; Swords D; Acher AW; Weber SM; Maithel SK; Pawlik T; Schmidt CR
Am Surg; 2018 Mar; 84(3):358-364. PubMed ID: 29559049
[TBL] [Abstract][Full Text] [Related]
38. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
[TBL] [Abstract][Full Text] [Related]
39. Postoperative infectious complications caused by multidrug-resistant pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection.
Sugawara G; Yokoyama Y; Ebata T; Igami T; Yamaguchi J; Mizuno T; Onoe S; Watanabe N; Nagino M
Surgery; 2020 Jun; 167(6):950-956. PubMed ID: 32303347
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the performance of the ACS NSQIP surgical risk calculator in gynecologic oncology patients undergoing laparotomy.
Rivard C; Nahum R; Slagle E; Duininck M; Isaksson Vogel R; Teoh D
Gynecol Oncol; 2016 May; 141(2):281-286. PubMed ID: 26899020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
